You are here

  • Home
  • Archive
  • Volume 7, Issue Suppl 1
  • 154: A PHARMACOECONOMIC EVALUATION TO MAKE DECISION: IS THE USE OF SIMVASTATIN 10 MG AS AN OTC MEDICATION COST-EFFECTIVE FOR THE PRIMARY PREVENTION OF STROKE AMONGST WOMEN IN IRAN?

Article metrics

Article menu

Download PDFPDF

XML
Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Iran
Oral
154: A PHARMACOECONOMIC EVALUATION TO MAKE DECISION: IS THE USE OF SIMVASTATIN 10 MG AS AN OTC MEDICATION COST-EFFECTIVE FOR THE PRIMARY PREVENTION OF STROKE AMONGST WOMEN IN IRAN?

 

Online download statistics by month:

Online download statistics by month: January 2018 to September 2025

AbstractFullPdf
Jan 20181201
Feb 2018801
Mar 20181400
Apr 2018802
May 20181000
Jun 20181400
Jul 2018800
Aug 20181200
Sep 20181403
Dec 2018200
Apr 2019200
May 2019400
Jun 20191800
Jul 20192200
Aug 2019401
Oct 2019804
Nov 20192800
Dec 2019400
Jan 20201601
Feb 20201601
Mar 2020601
May 2020200
Jun 2020801
Jul 20201200
Aug 2020800
Sep 20201404
Oct 2020601
Nov 2020201
Dec 20201401
Jan 2021801
Feb 2021001
Jun 2021001
Jul 2021002
Sep 2021001
Oct 20215000
Nov 20211802
Dec 20217802
Jan 202212404
Feb 202213000
Mar 202219802
Apr 20229502
May 20229301
Jun 20227601
Jul 20222400
Aug 20222401
Sep 20223000
Oct 20223200
Nov 20221208
Dec 20221008
Jan 2023600
Feb 20231102
Mar 2023602
Apr 20232600
May 20232004
Jun 2023200
Jul 2023805
Aug 2023901
Sep 2023500
Oct 20231000
Nov 20232001
Dec 20231501
Jan 20241200
Feb 2024200
Mar 2024400
Apr 20242601
May 20245403
Jun 20243603
Jul 20241205
Aug 2024903
Sep 2024802
Oct 20242201
Nov 20244802
Dec 20241802
Jan 20253201
Feb 2025002
Mar 2025304
Apr 2025109
May 2025003
Jun 2025003
Jul 2025202
Aug 2025306
Sep 2025002
Total17280130